Day: January 18, 2022

AMD to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results

AMD to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results

SANTA CLARA, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) announced today that it will report fourth quarter and full year 2021 financial results on Tuesday, Feb. 1, 2022, after the close of market. Management will conduct a conference call to discuss these results at 5:00 p.m. EST / 2:00 p.m. PST. Interested parties are invited to listen to the webcast of the conference call via AMD’s Investor Relations website ir.amd.com. About AMD For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the data center. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and...

Continue reading

Ryman Hospitality Properties, Inc. Announces Extension of Closing Date for Acquisition of Block 21 in Austin, Texas

Ryman Hospitality Properties, Inc. Announces Extension of Closing Date for Acquisition of Block 21 in Austin, Texas

NASHVILLE, Tenn., Jan. 18, 2022 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) announced today that the closing date for its acquisition of Block 21, a mixed-use entertainment, lodging, office, and retail complex located in downtown Austin, Texas, from Stratus Properties Inc. (NASDAQ: STRS) has been extended, as the parties continue the process of obtaining consent to the assumption of the property’s existing mortgage loan by an affiliate of the Company from the applicable loan servicers. The acquisition is now expected to close sometime in the first quarter of 2022, subject to the timely satisfaction or waiver of various closing conditions, including the consent of the loan servicer to the assumption of the existing mortgage loan, the consent of the hotel operator, an affiliate of Marriott, to...

Continue reading

Concentrix Reports Fiscal 2021 Fourth Quarter and Full Year Results

Concentrix Reports Fiscal 2021 Fourth Quarter and Full Year Results

FREMONT, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) solutions and technology, today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2021.   Three Months Ended       Fiscal Year Ended       November 30, 2021   November 30, 2020   Change   November 30, 2021   November 30, 2020   Change Revenue ($M) $ 1,466.6     $ 1,300.9     12.7 %   $ 5,587.0     $ 4,719.5     18.4 % Operating income ($M) $ 157.9     $ 120.2     31.4 %   $ 572.4     $ 308.8     85.4 % Non-GAAP operating income ($M) (1) $ 203.4     $ 175.4     16.0 %   $ 733.7     $ 509.4     44.0 % Operating margin   10.8 %     9.2 %   160 bps     10.2 %     6.5 %   370 bps Non-GAAP operating margin (1)   13.9 %     13.5 %   40...

Continue reading

Progress Reports 2021 Fiscal Fourth Quarter and Year End Results

Progress Reports 2021 Fiscal Fourth Quarter and Year End Results

Q4 and FY21 Revenue and EPS Significantly Ahead of GuidanceIntegration of Kemp On Target as Acquisition Drives Projected Fiscal 2022 Revenue Growth BEDFORD, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact applications, today announced financial results for its fiscal fourth quarter and fiscal year ended November 30, 2021. Fourth Quarter 2021 Highlights: Revenue of $140.1 million increased 14% year-over-year on an actual currency basis and 15% year-over-year on a constant currency basis. Non-GAAP revenue of $143.7 million increased 11% on both an actual currency basis and a constant currency basis. Annualized Recurring Revenue (“ARR”) of $486 million increased 12% year-over-year on a constant currency basis. Operating margin...

Continue reading

River Valley Community Bancorp Announces 4th Quarter and Annual Results (Unaudited); Opens Reno, Nevada Loan Production Office

River Valley Community Bancorp Announces 4th Quarter and Annual Results (Unaudited); Opens Reno, Nevada Loan Production Office

YUBA CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — River Valley Community Bancorp (OTC markets: RVCB) with its wholly owned subsidiary, River Valley Community Bank (collectively referred to as the “Bank”), today announced financial results for the quarter ended December 31, 2021. Consolidated financial highlights: Total assets ended the year at $600.8 million as of December 31, 2021, compared to $496.5 million as of December 31, 2020, and $527.7 million as of September 30, 2021. Total assets grew 21.0% during the year ended December 31, 2021. Net income for the quarter ended December 31, 2021, totaled $1.4 million or $0.44 per diluted share compared to $1.3 million or $0.46 per diluted share for the quarter ended December 31, 2020, and $1.4 million or $0.45 per diluted share for the quarter ended September 30, 2021. Net income...

Continue reading

Duke Realty Corporation (NYSE: DRE) Announces the Income Tax Characteristics of its 2021 Common Share Dividends

Duke Realty Corporation (NYSE: DRE) Announces the Income Tax Characteristics of its 2021 Common Share Dividends

INDIANAPOLIS, Jan. 18, 2022 (GLOBE NEWSWIRE) — Duke Realty Corporation (NYSE: DRE) announces the income tax characteristics of its 2021 common share dividends. Shareholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of Duke Realty Corporation’s dividends. Common Share Dividends:Ticker Symbol DRE, CUSIP # 264411505 PaymentDate Total 2021DistributionPer Share TotalOrdinaryDividends QualifiedDividends (1) Total CapitalGainDistribution UnrecapturedSection 1250Gain(2) Section199ADividends(3) Form 1099-DIV BoxNumber   1a 1b 2a 2b 5 2/26/2021 $0.255000 $0.233247 $0.012764 $0.021753 $0.010730 $0.220483 6/1/2021 0.255000 0.233247 0.012764 0.021753 0.010730 0.220483 8/31/2021 0.255000 0.233247 0.012764 0.021753 0.010730 0.220483 11/30/2021 0.280000 0.256114 0.014015 0.023886 0.011782 0.242099 2021...

Continue reading

Chicken Soup for the Soul Entertainment Announces Timing of Regular Monthly Dividend for February for Series A Cumulative Redeemable Perpetual Preferred Stock

Chicken Soup for the Soul Entertainment Announces Timing of Regular Monthly Dividend for February for Series A Cumulative Redeemable Perpetual Preferred Stock

COS COB, Conn., Jan. 18, 2022 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE, CSSEP, CSSEN), one of the largest operators of streaming advertising-supported video on-demand (“AVOD”) networks, today announced the timing for the payment of its declared regular monthly dividend of $0.2031 per share of its 9.75% Series A Cumulative Redeemable Perpetual Preferred Stock for February 2022. The dividend will be payable on February 15, 2022 to holders of record as of January 31, 2022. The dividend will be paid in cash. ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENT Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) (the “Company”) operates streaming video-on-demand networks (VOD). The Company owns Crackle Plus, which owns and operates a variety of ad-supported and subscription-based VOD networks including...

Continue reading

Orion Energy Systems Preliminarily Expects Q3’22 Revenue of Approximately $30.5M, Reduces FY 2022 Revenue Outlook to $130M and Holds Investor Call Today at 5:00pm ET

Orion Energy Systems Preliminarily Expects Q3’22 Revenue of Approximately $30.5M, Reduces FY 2022 Revenue Outlook to $130M and Holds Investor Call Today at 5:00pm ET

MANITOWOC, Wis., Jan. 18, 2022 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, controls and IoT systems, including turnkey project implementation, program management and system maintenance, announced today that it preliminarily expects revenue of approximately $30.5M for its FY 2022 third quarter ended December 31, 2021. Due to customer delays on several larger LED lighting and controls projects, primarily caused by the response of customers to supply chain disruptions and COVID-19 related impacts to their businesses, Orion now anticipates FY 2022 revenue of approximately $130M, as compared to its prior expectation of at least $150M. Orion’s updated FY 2022 revenue outlook represents growth of approximately 11% over FY 2021 revenue of $116.8M. Orion will...

Continue reading

JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN      

JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN    

Mechelen, Belgium; 18 January 2022; 22.01 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorization for Jyseleca®(filgotinib 200mg tablets), as a new treatment for ulcerative colitis (UC) for Great Britain. The MHRA has licensed an additional indication for Jyseleca, an oral once-daily, JAK1 preferential inhibitor, for use in adult patients with moderately to severely active UC who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent. The submission was supported by data from the Phase 2b/3 SELECTION program, published in the Lancet1. The decision from the MHRA follows authorisation from the European Commission (EC) for use in the same patient population. Michele...

Continue reading

Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research

Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research

DURHAM, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that a peer-reviewed article entitled, “Phase 2 Study of ONC201 in Neuroendocrine Tumors including Pheochromocytoma-Paraganglioma (PC-PG) and Desmoplastic Small Round Cell Tumor (DSRCT),” has been published in the journal, Clinical Cancer Research. The article can be accessed here. An interim summary of select cohorts from this study was previously presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in 2021. ONC201 is an orally administered small molecule dopamine receptor D2 (DRD2) antagonist and caseinolytic protease (ClpP) agonist.   “Given ONC201’s demonstrated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.